Hemangioblastomas of central nervous system: Molecular genetic analysis and clinical management

Neurosurgery

Volumn 56, Issue 6, 2005, Pages 1215-1221

  Catapano, Domenico ^a   Muscarella, Lucia Anna ^a   Guarnieri, Vito ^a   Zelante, Leopolde ^a   D'Angelo, Vincenzo Antonio ^a   D'Agruma, Leonardo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Germline mutation; Hemangioblastoma; VHL gene; Von Hippel Lindau disease

Indexed keywords

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL MEDICINE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ECONOMIC ASPECT; FAMILY HISTORY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HEMANGIOBLASTOMA; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MOLECULAR GENETICS; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; VHL GENE; VON HIPPEL LINDAU DISEASE;

ADULT; AGED; ARGININE; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HEMANGIOBLASTOMA; HIPPEL-LINDAU DISEASE; HUMANS; LEUCINE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; MUTATION, MISSENSE; PROLINE; RETROSPECTIVE STUDIES; TRYPTOPHAN; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 20044364376     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000159646.15026.D6     Document Type: Article

References (53)

1. Beroud C, Joly D, Gallon C, Staroz F, Orfanelli MT, Junien C: Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26:256-258, 1998.
2. Böhling T, Plate KH, Haltia M: Von Hippel Lindau disease and capillary hemangioblastoma, in Kleihues P, Cavenee (eds): Pathology and Genetics of Tumors of the Nervous System: World Health Organization Classification Of Tumours. Lyon, IARC Press, 2000, ed 2, pp 223-226.
3. Bradley JF, Collins DL, Schimke RN, Parrott HN, Rothberg PG: Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene. Am J Med Genet 87:163-167, 1999.
4. Chen F, Slife L, Kishida T, Mulvihill J, Tisherman SE, Zbar B: Genotype-phenotype correlation in von Hippel-Lindau disease: Identification of a mutation associated with VHL type 2A. J Med Genet 33:716-717, 1996.
5. Choyke PL, Glenn GM, Walther MM: Von Hippel-Lindau disease: Genetic, clinical and imaging features. Radiology 194:629-642, 1995.
6. Cline J, Bramam JC, Hogrefe HH: PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerase. Nucleic Acids Res 24:3546-3551, 1996.
7. Constans JP, Meder F, Maiuri F, Donzelli R, Spaziante R, de Divitiis E: Posterior fossa hemangioblastomas. Surg Neurol 25:269-275, 1986.
8. Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:55-63, 2001.
9. Couch V, Lindor NM, Karnes PS, Michels W: Von Hippel-Lindau disease. Mayo Clin Proc 75:265-272, 2000.
10. Friedrich CA: Von Hippel-Lindau syndrome: A pleomorphic condition. Cancer 86:2478-2482, 1999.
11. Gallou C, Chauveau D, Richard S, Joly D, Giraud S, Olschwang S, Martin N, Saquet C, Chretien Y, Mejean A, Correas JM, Benoit G, Colombeau P, Grunfeld JP, Junien C, Beroud C: Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat 24:215-224, 2004.
12. Glasker S, Bender BU, Apel TW, Natt E, van Velthoven V, Scheremet R, Zentner J, Neumann HP: The impact of molecular genetic analysis of the VHL gene in patients with hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 67:758-762, 1999.
13. Gong K, Zhang N, Guo HF, Zhang ZW, Xin DQ, Na YQ: Frequent somatic mutations of the von Hippel Lindau tumor suppressor gene and its meaning in sporadic human clear cell carcinoma [in Chinese]. Beijing Da Xue Xue Bao 36:169-172, 2004.
14. Guo HF, Gong K, Zou SM, Zhang ZW, Liu XY, Na X, Wu G, Na Y: Somatic mutations of VHL gene and HIF-1α expression in primary renal clear cell carcinomas [in Chinese]. Zhonghua Wai Ke Za Zhi 42:196-200, 2004.
15. Hes FJ, van der Luijt RB: Von Hippel-Lindau disease: Protocols for diagnosis and periodical clinical monitoring-National Von Hippel-Lindau Disease Working Group [in Dutch]. Ned Tijdschr Geneeskd 144:505-509, 2000.
16. Hes FJ, Lips CJ, van der Luijt RB: Molecular genetic aspects of von Hippel-Lindau disease and criteria for DNA analysis in subject at risk. Neth J Med 59:235-243, 2001.
17. Hes FJ, McKee S, Taphoorn MJ, Rehal P, van der Luijt RB, McMahon R, van der Smagt JJ, Dow D, Zewald RA, Whittaker J, Lips CJ, MacDonald F, Pearson PL, Maher ER: Cryptic von Hippel-Lindau disease: Germline mutation in patients with hemangioblastoma only. J Med Genet 37:939-943, 2000.
18. Hes FJ, van der Luijt RB, Lips CJ: Clinical management of von Hippel-Lindau (VHL) disease. Neth J Med 59:225-234, 2001.
19. Humphrey JS, Klausner RD, Linehan WM: Von Hippel-Lindau syndrome: Hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene. Cancer Treat Res 88:13-22, 1996.
20. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847, 1994.
21. Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System: World Health Organization Classification Of Tumours. Lyon, IARC Press, 2000.
22. Lamiell JM, Salazar FG, Hsia YE: Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 68:1-29, 1989.
23. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DR, Dean A, Glavac D, Richard FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault CA, Maher ER, Linehan WM, Zbar B: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993.
24. Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky LA, Linehan WM, Worrmeyer AO, Zhuang Z: Loss of heterozygosity and somatic mutation of the VHL suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58:504-508, 1998.
25. Linehan WM, Lerman MI, Zbar B: Identification of the von Hippel-Lindau gene: Its role in renal cancer. JAMA 273:564-570, 1995.
26. Lynch HT, Watson P, Shaw TG, Lynch JF, Harty AE, Franklin BA, Kapler CR, Tinley ST, Liu B: Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Cancer 86:2449-2456, 1999.
27. Maddock IR, Moran A, Maher ER, Teare MD, Normann A, Payne SJ, Whitehouse R, Dodd C, Lavin M, Hartley N, Super M, Evans DG: A genetic register for von Hippel-Lindau disease. J Med Genet 33:120-127, 1996.
28. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N: Von Hippel-Lindau disease: A genetic study. J Med Genet 28:443-447, 1991.
29. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT: Phenotypic expression in von Hippel-Lindau disease: Correlations with germline VHL gene mutations. J Med Genet 33:328-332, 1996.
30. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA: Clinical features and natural history of Von Hippel-Lindau disease. Q J Med 77:1151-1163, 1990.
31. Marsh DJ, Theodosopoulos G, Howell V, Richardson AL, Benn DE, Proos AL, Eng C, Robinson BG: Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia 3:236-244, 2001.
32. Melmon KL, Rosen SW: Lindau's disease: Review of the literature and study of a large kindred. Am J Med 36:595-617, 1964.
33. Neumann HP, Bender BU: Genotype-phenotype correlations in von Hippel-Lindau disease. J Intern Med 243:541-545, 1998.
34. Neumann HP, Eggert HR, Weigel K, Freidburg H, Wiestler OD, Schollmeyer P: Hemangioblastoma of the central nervous system; A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70:24-30, 1989.
35. Niemela M, Lemeta S, Summanen P, Bohling T, Sainio M, Kere J, Poussa K, Sankila R, Haapasalo H, Kaariainen H, Pukkala E, Jääskeläinen J: Long-term prognosis of hemangioblastoma of the CNC: Impact of von Hippel-Lindau disease. Acta Neurochir (Wien) 141:1147-1156, 1999.
36. Niemela M, Lim YJ, Soderman M, Jääskeläinen J, Lindquist C: Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg 85:591-596, 1996.
37. Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP: Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary hemangioblastoma of the central nervous system. J Pathol 179:151-156, 1996.
38. Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, Thomas G: Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum Mutat 12:424-430, 1998.
39. Patrice SJ, Sneed PK, Flickinger JC, Shrieve DC, Pollock BE, Alexander E III, Larson DA, Kondziolka D, Gutin PH, Wara WM, McDermott MW, Lunsford LD, Loeffler JS: Radiosurgery for hemangioblastoma: Results of a multi-institutional experience. Int J Radiat Oncol Biol Phys 35:493-499, 1996.
40. Richard S, Beigelman C, Gerber S, Van Effenterre R, Gaudric A, Sahel M: Does hemangioblastoma exist outside von Hippel-Lindau disease? [in French]. Neurochirurgie 40:145-154, 1994.
41. Richard S, Campello C, Taillandier L, Parker F, Resche F: Hemangioblastoma of the central nervous system in von Hippel-Lindau disease: French VHL Study Group. J Intern Med 243:547-553, 1998.
42. Richard S, David P, Marsot-Dupuch K, Giraud S, Beroud C, Resche F: Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev 23:1-24, 2000.
43. Ruiz-Llorente S, Bravo J, Cebrian A, Cascon A, Pollan M, Telleria D, Leton R, Urioste M, Rodriguez-Lopez R, de Campos JM, Munoz MJ, Lacambra C, Benitez J, Robledo M: Generic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations. Hum Mutat 23:160-169, 2004.
44. Sora S, Ueki K, Saito N, Kawahara N, Shitara N, Kirino T: Incidence of von Hippel-Lindau disease in hemangioblastoma patients: The University of Tokyo Hospital experience from 1954-1998. Acta Neurochir (Wien) 143: 893-896, 2001.
45. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M: Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:417-423, 1998.
46. Surawicz TS, McCarthy BJ, Kupelian V, Jukivh PJ, Bruner JM, Davs FG: Descriptive epidemiology of the primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neurooncology 1:14-25, 1999.
47. Tampieri D, Leblanc R, ter Brugge K: Preoperative embolization of brain and spinal hemangioblastoma. Neurosurgery 33:502-505, 1993.
48. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH: Von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540-543, 1997.
49. Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B, Linehan WM: Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: Comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162[Suppl 3]:659-664, 1999.
50. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82-94, 2003.
51. Xiao W, Oefner PJ: Denaturing high-performance liquid chromatography: A review. Human Mutat 17:439-474, 2001.
52. Zbar B, Kaelin W, Maher E, Richard S: Third International Meeting on von Hippel-Lindau disease. Cancer Res 59:2251-2253, 1999.
53. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Glavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CH, Lerman M, et al: Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348-357, 1996.